402 related articles for article (PubMed ID: 26796305)
21. Histone modifying enzymes and cancer: going beyond histones.
Zhang K; Dent SY
J Cell Biochem; 2005 Dec; 96(6):1137-48. PubMed ID: 16173079
[TBL] [Abstract][Full Text] [Related]
22. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development.
Maleszewska M; Kaminska B
Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459
[TBL] [Abstract][Full Text] [Related]
23. Histone modifications in response to DNA damage.
Altaf M; Saksouk N; Côté J
Mutat Res; 2007 May; 618(1-2):81-90. PubMed ID: 17306843
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal histone modification patterns--from conservation to diversity.
Fuchs J; Demidov D; Houben A; Schubert I
Trends Plant Sci; 2006 Apr; 11(4):199-208. PubMed ID: 16546438
[TBL] [Abstract][Full Text] [Related]
25. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression.
Shilatifard A
Annu Rev Biochem; 2006; 75():243-69. PubMed ID: 16756492
[TBL] [Abstract][Full Text] [Related]
26. Role of Histone-Modifying Enzymes and Their Complexes in Regulation of Chromatin Biology.
DesJarlais R; Tummino PJ
Biochemistry; 2016 Mar; 55(11):1584-99. PubMed ID: 26745824
[TBL] [Abstract][Full Text] [Related]
27. Metabolic regulation of histone post-translational modifications.
Fan J; Krautkramer KA; Feldman JL; Denu JM
ACS Chem Biol; 2015 Jan; 10(1):95-108. PubMed ID: 25562692
[TBL] [Abstract][Full Text] [Related]
28. Engineering chromatin states: chemical and synthetic biology approaches to investigate histone modification function.
Pick H; Kilic S; Fierz B
Biochim Biophys Acta; 2014 Aug; 1839(8):644-56. PubMed ID: 24768924
[TBL] [Abstract][Full Text] [Related]
29. Histone phosphorylation: a chromatin modification involved in diverse nuclear events.
Rossetto D; Avvakumov N; Côté J
Epigenetics; 2012 Oct; 7(10):1098-108. PubMed ID: 22948226
[TBL] [Abstract][Full Text] [Related]
30. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy.
Zheng YG; Wu J; Chen Z; Goodman M
Med Res Rev; 2008 Sep; 28(5):645-87. PubMed ID: 18271058
[TBL] [Abstract][Full Text] [Related]
31. Simple histone acetylation plays a complex role in the regulation of gene expression.
Fukuda H; Sano N; Muto S; Horikoshi M
Brief Funct Genomic Proteomic; 2006 Sep; 5(3):190-208. PubMed ID: 16980317
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation and chromatin modifiers in colorectal cancer.
Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
[TBL] [Abstract][Full Text] [Related]
33. Protein arginine methyltransferases (PRMTs): role in chromatin organization.
Jahan S; Davie JR
Adv Biol Regul; 2015 Jan; 57():173-84. PubMed ID: 25263650
[TBL] [Abstract][Full Text] [Related]
34. Reversible acetylation of non histone proteins: role in cellular function and disease.
Batta K; Das C; Gadad S; Shandilya J; Kundu TK
Subcell Biochem; 2007; 41():193-212. PubMed ID: 17484129
[TBL] [Abstract][Full Text] [Related]
35. Covalent modifications of histones during development and disease pathogenesis.
Bhaumik SR; Smith E; Shilatifard A
Nat Struct Mol Biol; 2007 Nov; 14(11):1008-16. PubMed ID: 17984963
[TBL] [Abstract][Full Text] [Related]
36. Histone modification enzymes: novel targets for cancer drugs.
Kristeleit R; Stimson L; Workman P; Aherne W
Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
[TBL] [Abstract][Full Text] [Related]
37. Histone acetylation and chromatin signature in stem cell identity and cancer.
Shukla V; Vaissière T; Herceg Z
Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
[TBL] [Abstract][Full Text] [Related]
38. Histone Modifications and Cancer.
Audia JE; Campbell RM
Cold Spring Harb Perspect Biol; 2016 Apr; 8(4):a019521. PubMed ID: 27037415
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs.
Farooqi AA; Fayyaz S; Poltronieri P; Calin G; Mallardo M
Semin Cancer Biol; 2022 Aug; 83():197-207. PubMed ID: 32738290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
